Gerard Ber - Jun 10, 2024 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
Director
Signature
/s/ John LaRocca, Attorney-in-Fact
Stock symbol
YMAB
Transactions as of
Jun 10, 2024
Transactions value $
-$8,664
Form type
4
Date filed
6/11/2024, 07:54 PM
Previous filing
May 13, 2024
Next filing
Aug 14, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale -$8.66K -722 -30.99% $12.00 1.61K Jun 10, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Gerard Ber is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $12.00 to $12.015, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.